DM
ORGO icon

Deerfield Management’s Organogenesis Holdings ORGO Stock Holding History

Deerfield Management’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4,447,740
Closed -$21.7M – 134
2022
Q2 		$21.7M Sell
4,447,740
-4,009,136
-47% -$24.7M 0.45% 57
2022
Q1 		$64.4M Hold
8,456,876
– – 1.44% 25
2021
Q4 		$78.1M Buy
8,456,876
+994,333
+13% +$10.6M 1.64% 17
2021
Q3 		$106M Buy
7,462,543
+240,416
+3% +$3.73M 2.07% 12
2021
Q2 		$120M Buy
7,222,127
+4,226,489
+141% +$78.8M 2.13% 10
2021
Q1 		$54.6M Buy
+2,995,638
New +$40.6M 1.15% 25

Other funds holding ORGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Deerfield Management's ORGO Position: Q3 2022 in Review

Deerfield Management sold out of Organogenesis Holdings (ORGO) in Q3 2022, closing a stake of 4,447,740 shares — an estimated $21.7M sold.

Deerfield Management first reported a position in ORGO in Q1 2021 and held it in 6 quarters. The position peaked at $120M in Q2 2021. 154 funds tracked by Wall St. Rank hold ORGO as of Q3 2022.

  • Deerfield Management reported no remaining Organogenesis Holdings position as of Q3 2022 after selling out during the quarter.
  • Deerfield Management sold 4,447,740 Organogenesis Holdings shares in Q3 2022, an estimated $21.7M.
  • Deerfield Management first reported a position in Organogenesis Holdings in Q1 2021 and held it in 6 quarters.
  • Deerfield Management's Organogenesis Holdings position peaked at $120M in Q2 2021.
  • 154 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2022.

Based on Deerfield Management's 13F filing for Q3 2022, filed 14 Nov 2022.